Aviron Message Board - Msg: 1874946

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.070

-12.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (66)	7/31/1997 7:54:00 AM
From: Haolin Ni	of 645

Hi, Pseudo. We need to emphasize the critical point of a vaccine whcih could provent the fatal disease and have a long lasting effect will have a bright future. Every one would be more than willing to take a vaccine against AIDS but they don't have to take a vaccine against flu every year. This critical point limited the price of the flu vaccine so that the profit margin of flu could not be high. It is also very clear a new flu vaccine can never take away the whole market in one night when the effeacy is not much different. As you mentioned that >>PMC, Merck, Cortecs - working on an oral version<<. Therefore, the flu vaccine of AVIR will has 148 million dose per year is way off the market. The prediction of such big market is obvious a hype to me. I don't think the posts in here could change someone has fixed opinion but no one can deny that flu is not fatal disease.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next